https://www.marketscreener.com/quote/stock/ARBUTUS-BIOPHARMA-CORPORA-23319313/news/Arbutus-Biopharma-and-Vaccitech-Dose-First-Patient-in-Phase-2a-Clinical-Trial-Combining-Therapies-40649981/?utm_source=telegram&utm_medium=social&utm_campaign=share